SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-20-000254
Filing Date
2020-04-02
Accepted
2020-04-02 17:30:35
Documents
6
Period of Report
2020-04-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm 8-K 48915
2 EXHIBIT 10.1 ex10x1.htm EX-10.1 71867
3 EXHIBIT 10.4 ex10x4.htm EX-10.4 28524
4 EXHIBIT 10.6 ex10x6.htm EX-10.6 136767
5 EXHIBIT 99.1 ex99x1.htm EX-99.1 17115
6 GRAPHIC opgen_logov1.jpg GRAPHIC 5381
  Complete submission text file 0001079973-20-000254.txt   312086
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 20770373
SIC: 8071 Services-Medical Laboratories